BiondVax Pharma (BVXV) Reports Q1 Loss of NIS0.03/Share
Tweet
Share
E-mailGet Alerts BVXV Hot Sheet
Join SI Premium – FREE
BiondVax Pharma (NASDAQ: BVXV) reported Q1 EPS of (NIS0.03), versus (NIS0.04) reported last year.
For earnings history and earnings-related data on BiondVax Pharma (BVXV) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NIO Inc. (NIO) Tops Q2 EPS by 33c; offers guidance
- GitLab Inc (GTLB) Tops Q2 EPS by 7c, Beats on Revenue
- Stifel Reiterates Buy Rating on Palo Alto Networks (PANW)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
